Talphera (Ex. AcelRx)

2 Decision Makers · 3 Verified Contacts

📍 Redwood City, CABiotechnology🗓 Est. 2005👥 11–50 employees

About Talphera (Ex. AcelRx)

Talphera focuses on the development and commercialization of therapies for the treatment of pain and other conditions.

Leadership & Decision Makers

Contact details of 2 Talphera (Ex. AcelRx) decision makers

Pamela Pierce Palmer

Founder & Chief Medical Officer

Vincent J. Angotti

Chief Executive Officer

Team & Specialists

Contact details of 1 Talphera (Ex. AcelRx) team members

Kim Gaumer

Snr. Vice President, Regulatory and Quality Assurance,Vice President

General Emails

General company emails, e.g. customer support lines

    info@talphera.com

    General Inquiries

    info@acelrx.com

    General Inquiries

    vangotti@talphera.com

    Unclassified inbox

Similar Companies like Talphera (Ex. AcelRx)

Sorrento Therapeutics

sorrentotherapeutics.com
Pharmaceuticals · San Diego, CA · Est. 2006 · 101–250 employees · $500M–$1B

HQ: San Diego, CA

Cytokinetics

cytokinetics.com
Pharmaceuticals · South San Francisco, California, United States · Est. 1998 · 251–500 employees · $50M–$100M

HQ: South San Francisco, California, United States

BridgeBio

bridgebio.com
Biotechnology · Palo Alto, CA · Est. 2015 · 251–500 employees

HQ: Palo Alto, CA

Jazz Pharmaceuticals

jazzpharma.com
Biotechnology · Palo Alto, CA · Est. 2003 · 501–1000 employees · $500M–$1B

HQ: Palo Alto, CA

Loxo Oncology

loxooncology.com
Pharmaceuticals · New York, NY · Est. 2013 · 501–1000 employees

HQ: New York, NY

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 14/07/2025

650-216-6500

Redwood City, CA

Legal Name: Talphera, Inc
Business Type: Public
Employees: 11-50
Rounds: Debt Financing
Founded Date: 2005
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:TLPH
Operating Status: Active
Last Funding Type: Debt Financing
Phone Number: 650-216-6500
Last Investment Activity: Mar 6, 2024
Investments Activity: Mar 6, 2024 Mar 1, 2024 Feb 6, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.